Chargement en cours...
Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapy
Hepatocellular carcinoma (HCC) is a major cause of cancer-associated mortality worldwide and is expected to rise. Patients with early-stage disease may have a good prognosis with a 5-year survival rate of greater than 70%. However, the majority of patients are diagnosed with late-stage disease with...
Enregistré dans:
| Publié dans: | Therap Adv Gastroenterol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6202741/ https://ncbi.nlm.nih.gov/pubmed/30377451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284818808086 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|